Be the first person to write a business review for Ansell Limited

AorTech develops and manufactures medical-grade polyurethanes for use in medical devices and implants. Its products are based on the company's Elast-Eon materials which have various applications including in drug-eluting stents, in orthopedic devices (spinal discs), and for reconstructive/cosmetic uses (breast implants). The company's wholly-owned subsidiary, AorTech Biomaterials, based in Melbourne, Australia, was formed more than a decade ago to commercialize the company's range of medical-grade polyurethanes. Bluehone Investors (chaired by AorTech director Stuart Rollason) holds about 20% of the company's shares.

ApaTech has an appetite for orthopedics. The company's ApaPore product is a synthetic bone graft material used in the treatment of fractures and bone defects, as well as in spinal and joint surgeries. The company's Actifuse product is also a synthetic bone graft material, which is designed to promote bone growth. (In the US, both products are sold as bone void fillers only.) The company's headquarters and manufacturing facilities are in England, but ApaTech has operations in the US and Germany as well. US medical giant Baxter International acquired ApaTech in 2010 to gain access to the bone fusion market.

Applied Scintillation Technologies (AST) is a maker of imaging and detection products that utilize phosphor and scintillation technologies. More simply put, AST offers X-ray and other imaging devices that are used in the medical, dental, security, and instrumentation industries. Products include laser alignment devices, infrared digital cameras, phosphor screens, photometers, and radiometers. Founded in 1920, the company was originally called Levy West Laboratory and was an early maker of phosphors for X-ray machines. It was at one time a subsidiary of Levy Hill Group Plc, but members of AST's management (through an entity called TQ Scientific) bought the firm in 2007.

It's all about heart for Arrhythmia Research Technology (ART). The company offers signal-averaging electrocardiographic (SAECG) software that collects data and analyzes electrical impulses of the heart in an effort to detect potentially lethal heart arrhythmias. The company plans to sell the products through licensing agreements with equipment makers. Until it finds a marketing partner, however, ART is relying on sales from its Micron Products subsidiary, which makes snaps and sensors used in the manufacture and operation of disposable electrodes for electrocardiographic (ECG) equipment. Micron Products has acquired assets of several companies that enhance its metal and plastics molding capabilities.

ART Advanced Research Technologies manufactures laser-based diagnostic imaging devices for the medical and pharmaceutical industries. ART's Optix device allows scientists to use molecular imaging technology to study live animal subjects. The company's SoftScan device is used to detect and diagnose breast cancer. Both use light, rather than X-rays or soundwaves, in their applications. It also makes Fenestra contrast imaging agents. ART's products are distributed through direct sales efforts and via a strategic alliance with GE Healthcare. The company restructured under bankruptcy protection and was acquired by private financial firm Dorsky Worldwide in 2009.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.